A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)
Status:
Completed
Trial end date:
2009-11-19
Target enrollment:
Participant gender:
Summary
To investigate the long-term efficacy and safety of treatment with esmirtazapine (Org 50081,
SCH 900265, MK-8265) compared to placebo, in participants with chronic primary insomnia.
Primary efficacy variable is Total Sleep Time (TST).